| NCT Number | NCT07584213 |
| Lead Sponsor | Wenjin Yin |
| Conditions | Breast Cancer Invasive |
| Enrollment | 2,946 participants |
| Start Date | 2026-05-01 |
| Primary Completion | 2026-05-08 (estimated) |
| Study Completion | 2027-05-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-05-13 |